The scars of cancer prevention interventions and treatment are real, and not always visible.
As we recognize National Hereditary Cancer Week (Sept 28 – Oct 4), National Previvor Day (Oct 2), and Menopause Awareness Month (October), we would like to highlight the Gynecologic Cancer Prevention and Survivorship Program (GPS).
Guided by the mission to improve quality of life for people affected by gynecologic cancer hereditary risk or diagnosis, GPS makes it possible for patients to thrive. GPS provides evidence-based personalized care in hereditary cancer prevention, surgical decision making, survivorship, and menopause management.
Many hereditary cancer gene carriers (“previvors”) choose to take preventive measures, such as undergoing a risk-reducing salpingo-oophorectomy to lower their risk of ovarian cancer. While these interventions can be lifesaving, they often induce premature menopause and bring significant side effects. Patients frequently need clear, consistent, and ongoing support to navigate these changes. Access to specialized care, such as guidance on hormone therapy, can improve adherence, alleviate symptoms, and enhance overall quality of life.
Use of a virtual clinic model makes specialized care accessible to patients from all corners of British Columbia and the Yukon, serving over 400 patients across 1900+ visits as of 2021.
Learn more by visiting gpscancerprogram.org
Stay in the loop with the Gynecologic Cancer Initiative: